34 IDL certificates：CSC had been granted by NMPA from 2006 to 2017.
20 API products：CSC passed CDE’s technical review (A) by end of 2018.
25 API products：CSC has finished joint-application work with FDF customers which is in BE/CT phase.
44 API products with registration no. ( I ) ：CSC awaits NMPA’s final approval, 7 of them are IDL expired products.
152 API products：CSC is preparing register submission to NMPA.
52 products from India：CSC has commercialized by end of 2018.
281 products： CSC signed exclusive agency agreements with over 60 pharmaceutical manufacturers.
700 FDF customers：CSC has good business relationship in China market.
Over 37 million US dollars：CSC’s annual sales volume in 2018.
Over 3300 products &1000 companies：CSC built its own data base.